DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kim Y, Lee B, Shim JH. et al.
Concurrent genetic alterations predict the progression to target therapy in EGFR-mutated advanced NSCLC.
J Thorac Oncol 2019;
14 (02) 193-202
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.